1887
Volume 2014, Issue 1
  • ISSN: 0253-8253
  • E-ISSN: 2227-0426

Abstract

We conducted a retrospective cohort study to evaluate the clinical manifestations, laboratory findings, complications and treatment of brucellosis in the State of Qatar. The medical records of patients in Hamad Medical Corporation, Doha, Qatar were reviewed from January 2000 to December 2006. History, various socio-demographic features, clinical and biochemical parameters, therapeutic features, and complications were retrospectively collected from the patient database. Around three quarters of the study population were males. History of raw milk consumption and animal contact were seen in 41.7% and 12.5% respectively. The main presenting features of our cohort were fever, chills and sweating (93.1%, 62.5% and 58.3% respectively). Positive antibody titre (>1:160) was detected in 95.8% and positive blood culture was reported in 63.9% of the cohort. Splenomegaly was observed in 19.4%, hepatomegaly in 15.3% and lymphadenopathy in 9.7% of the cases. Approximately half of our patients were treated with a combination of doxycycline and streptomycine and nearly one quarter received doxycycline and rifampicine combination therapy. Brucellosis is an important public health problem worldwide. It is associated with significant morbidity and mortality. It may affect any organ system and can present with a variety of clinical features. Diagnosis of brucellosis requires serological tests with or without blood culture. Treatment with at least two antibiotics for six weeks or more appears to be effective.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2014.4
2014-07-01
2019-10-23
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2014/1/qmj.2014.4.html?itemId=/content/journals/10.5339/qmj.2014.4&mimeType=html&fmt=ahah

References

  1. [1]. Pappas   G., , Papadimitriou   P., , Akritidis   N., , Christou   L., , Tsianos   EV. . The new global map of human brucellosis. . Lancet Infect Dis . 2006; ;6: : 91– 99 .
    [Google Scholar]
  2. [2]. Awad   R. . Human brucellosis in the Gaza strip, Palestine. . East Mediterr Health J . 1998; ;4: : 225– 233 .
    [Google Scholar]
  3. [3]. Naparstek   E., , Block   CS., , Slavin   S. . Transmission of brucellosis by bone marrow transplantation. . Lancet . 1982; ;1: 8271 : 574– 575 .
    [Google Scholar]
  4. [4]. Lubani   M., , Sharda   D., , Helin   I. . Probable transmission of brucellosis from breast milk to a newborn. . Trop Geogr Med . 1988; ;40: 2 : 151– 152 .
    [Google Scholar]
  5. [5]. Mantur   BG., , Mangalgi   SS., , Mulimani   M. . Brucella melitensis–a sexually transmissible agent?.   Lancet . 1996; ;347: 9017 : 1763 .
    [Google Scholar]
  6. [6]. Tikare   NV., , Mantur   BG., , Bidari   LH. . Brucellar meningitis in an infant–evidence for human breast milk transmission. . J Trop Pediatr . 2008; ;54: 4 : 272– 274 .
    [Google Scholar]
  7. [7]. Kochar   DK., , Gupta   BK., , Gupta   A., , Kalla   A., , Nayak   KC., , Purohit   SK. . Hospital-based case series of 175 cases of serologically confirmed brucellosis in Bikaner. . J Assoc Physicians India . 2007; ;55: : 271– 275 .
    [Google Scholar]
  8. [8]. Mantur   BG., , Amarnath   SK., , Shinde   RS. . Review of clinical and laboratory features of human brucellosis. . Indian J Med Microbiol . 2007; ;25: 3 : 188– 202 .
    [Google Scholar]
  9. [9]. Mousa   AR., , Muhtaseb   SA., , Almudallal   DS., , Khodeir   SM., , Marafie   AA. . Osteoarticular complications of brucellosis: a study of 169 cases. . Rev Infect Dis . 1987; ;9: 3 : 531– 543 .
    [Google Scholar]
  10. [10]. Nicoletti   P. . Control, eradication and prevention of brucellosis. . In: Madkour   MM. , ed. Brucellosis . New York: : Springer;   2001; ; : 280– 285 .
    [Google Scholar]
  11. [11]. FAO/WHO . Report, Joint FAO/WHO Expert Committee on Brucellosis . Technical Report Series No. 740 . Geneva: : World Health Organization;   1986; .
    [Google Scholar]
  12. [12]. Ariza   J., , Gudiol   F., , Pallares   R., , Rufi   G., , Fernandez-Viladrich   P. . Comparative trial of rifampin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosis. . Antimicrob Agents Chemother . 1985; ;28: 4 : 548– 551 .
    [Google Scholar]
  13. [13]. Mantur   BG., , Biradar   MS., , Bidri   RC., , Mulimani   MS., , Veerappa., , Kariholu   P., , Patil   SB., , Mangalgi   SS. . Protean clinical manifestations and diagnostic challenges of human brucellosis in adults: 16 years’ experience in an endemic area. . J Med Microbiol . 2006; ;55: Pt 7 : 897– 903 .
    [Google Scholar]
  14. [14]. Solera   J., , Martinez-Alfaro   E., , Espinosa   A., , Castillejos   ML., , Geijo   P., , Rodriguez-Zapata   M. . Multivariate model for predicting relapse in human brucellosis. . J Infect Dis . 1998; ;36: : 85– 92 .
    [Google Scholar]
  15. [15]. Fallatah   SM., , Oduloju   AJ., , Al-Dusari   SN., , Fakunle   YM. . Human brucellosis in Northern Saudi Arabia. . Saudi Med J . 2005; ;26: 10 : 1562– 1566 .
    [Google Scholar]
  16. [16]. Jennings   GJ., , Hajjeh   RA., , Girgis   FY., , Fadeel   MA., , Maksoud   MA., , Wasfy   MO., , El-Sayed   N., , Srikantiah   P., , Luby   SP., , Earhart   K., , Mahoney   FJ. . Brucellosis as a cause of acute febrile illness in Egypt. . Trans R Soc Trop Med Hyg . 2007; ;101: 7 : 707– 713 .
    [Google Scholar]
  17. [17]. Buzgan   T., , Karahocagil   MK., , Irmak   H., , Baran   AI., , Karsen   H., , Evirgen   O., , Akdeniz   H. . Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature. . Int J Infect Dis . 2010; ;14: 6 : e469– e478 .
    [Google Scholar]
  18. [18]. Tanir   G., , Tufekci   SB., , Tuygun   N. . Presentation, complications, and treatment outcome of brucellosis in Turkish children. . Pediatr Int . 2009; ;51: : 114– 119 .
    [Google Scholar]
  19. [19]. Ulug   M., , Can-Ulug   N., , Selek   Ç. . Akut brusellozlu hastalarda akut faz reaktanlarinin düzeyi. . Klimik Dergisi . 2010; ;23: : 48– 50 .
    [Google Scholar]
  20. [20]. Al-Eissa   Y., , AI-Nasser   M. . Hematological manifestation of childhood brucellosis. . Infection . 1993; ;21: : 23– 26 .
    [Google Scholar]
  21. [21]. Dilek   I., , Durmus   A., , Karahocagil   MK., , Akdenyz   H., , Karsen   H., , Baran   AI., , Evirgen   Ö. . Hematological complications in 787 cases of acute brucellosis in eastern Turkey. . Turk J Med Sci . 2008; ;38: : 421– 424 .
    [Google Scholar]
  22. [22]. Ertek   M., , Yazgi   H., , Kadanali   A., , Ozden   K., , Tasyaran   MA. . Complications of Brucella infection among adults: an 18-year retrospective evaluation. . Turk J Med Sci . 2006; ;36: : 377– 381 .
    [Google Scholar]
  23. [23]. Bukharie   HA. . Clinical features, complications and treatment outcome of Brucella infection: ten years’ experience in an endemic area. . Trop J Pharm Res . 2009; ;8: : 303– 310 .
    [Google Scholar]
  24. [24]. Lulu   AR., , Araj   GF., , Khateeb   MI., , Mustafa   MY., , Yusuf   AR., , Fenech   FF. . Human brucellosis in Kuwait: a prospective study of 400 cases. . QJ Med . 1988; ;66: : 39– 54 .
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.2014.4
Loading
/content/journals/10.5339/qmj.2014.4
Loading

Data & Media loading...

  • Article Type: Research Article
Keyword(s): Brucellosis , Malta fever , Middle East and Qatar
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error